Washington 2025-2026 Regular Session Status: Passed House 4 D cosponsors

HB 2402 — Concerning phthalates in medical equipment used for intravenous purposes.

Last action — Referred to Rules 2 Review.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the House. Introduced January 13, 2026. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the Senate.

Odds of enactment

Moderate chance

Based on the sponsor, cosponsors, and committee posture, this bill has a moderate chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 34% · moderate confidence

  • Passed House

    Current position in the legislative process.

  • 4 sponsors

    1 primary, 3 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (4 D).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

24 added · 47 removed

Plain-language change summary

The latest version of House Bill 2402 has changed the implementation date for a ban on intravenous solution containers containing DEHP from January 1, 2030, to January 1, 2028. This earlier date means that healthcare providers will have to find alternatives to DEHP sooner, which is important because DEHP can be harmful to patients, especially vulnerable populations like infants. Additionally, the previous version included provisions allowing for an extended compliance date under certain conditions, which have now been removed, emphasizing a stricter approach to the ban. This change is significant as it reflects a stronger commitment to reducing the use of potentially dangerous chemicals in healthcare settings.

→
Previous
Latest
H-3353.1 SUBSTITUTE HOUSE BILL 2402 State of Washington 69th Legislature 2026 Regular Session By House Health Care & Wellness (originally sponsored by Representatives Stonier, Parshley, Ramel, and Reed) READ FIRST TIME 02/04/26.
H-2542.3 HOUSE BILL 2402 State of Washington 69th Legislature 2026 Regular Session By Representatives Stonier, Parshley, Ramel, and Reed Read first time 01/13/26.
Referred to Committee on Environment & Energy.
1 SHB 2402 (6) Studies have suggested a potential link between DEHP exposure and certain types of cancer, including breast, liver, lung, and testicular cancer.
1 HB 2402 (6) Studies have suggested a potential link between DEHP exposure and certain types of cancer, including breast, liver, lung, and testicular cancer.
2 SHB 2402 (5) "Ortho-phthalates" means a class of chemicals that are esters of ortho-phthalic acid, including all of the following:
2 HB 2402 (5) "Ortho-phthalates" means a class of chemicals that are esters of ortho-phthalic acid, including all of the following:
(1) Except as provided in subsections (4) through (6) of this section, beginning January 1, 2030, it is prohibited for a person to manufacture, sell, or distribute into commerce in Washington intravenous solution containers made with intentionally added DEHP or that contain unintentionally added DEHP in a quantity that equals or exceeds 0.1 percent weight per weight.
(1) Except as provided in subsections (4) and (5) of this section, beginning January 1, 2028, it is prohibited for a person to manufacture, sell, or distribute into commerce in Washington intravenous solution containers made with intentionally added DEHP or that contain unintentionally added DEHP in a quantity that equals or exceeds 0.1 percent weight per weight.
(5) A person or entity, due to pending United States food and drug administration approval for the DEHP-free intravenous solution container or due to the manufacturer not having adequate equipment to p.
(5) Nothing in this section limits the authority of the department of ecology with respect to DEHP, other ortho-phthalates, p.
3 SHB 2402 manufacture the DEHP-free intravenous solution container, shall meet the requirement in subsection (1) of this section by January 1, 2032, if both of the following conditions are met:
3 HB 2402 intravenous solution containers, or intravenous tubing under chapter 70A.350 RCW.
(a) The person or entity notified its Washington customers, no later than January 1, 2027, that it has commenced development of the DEHP-free intravenous solution container to meet the requirements of this section;
and (b) The person or entity provides notice to its customers and posts to its official internet website, no later than January 1, 2028, that it will not meet the deadline imposed pursuant to subsection (1) of this section.
(6) If the United States food and drug administration or Washington department of health determines that there is an industry shortage of federal food and drug administration approved intravenous solution containers and tubing, such federal food and drug administration approved intravenous solution containers and tubing containing DEHP may be manufactured, distributed, and sold within Washington until the federal food and drug administration or Washington department of health determines the supply chain interruption is terminated.
(7) Nothing in this section limits the authority of the department of ecology with respect to DEHP, other ortho-phthalates, intravenous solution containers, or intravenous tubing under chapter 70A.350 RCW.
4 SHB 2402
4 HB 2402
⬇ Download PDF
View plain text versions (2)

Action History

  1. Referred to Rules 2 Review.

  2. Minority; without recommendation.

  3. HCW - Majority; 1st substitute bill be substituted, do pass.

  4. Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.

  5. Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.

  6. Referred to Health Care & Wellness.

  7. Committee relieved of further consideration.

  8. First reading, referred to Environment & Energy.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 3 co-sponsors · 147 not signed on

Sponsors (1)

Co-sponsors (3)

Not signed on (147)

147 members have not signed on to this bill.

Show all 147 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 2402?
HB 2402 is sponsored by Julia Reed (Democrat), Alex Ramel (Democrat), Lisa Parshley (Democrat), and Monica Jurado Stonier (Democrat).
What is the current status of HB 2402?
This bill has passed the House. Introduced January 13, 2026. It now moves to the second chamber.
Where can I track HB 2402?
Track HB 2402 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2402

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2402

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →